PERITONEAL CARCINOMATOSIS. REVIEW OF WORLD EXPERIENCE
https://doi.org/10.24060/2076-3093-2013-0-4-115-119
Abstract
During the last three decades, the understanding of the biology and pathways of dissemination of tumors with intraperitoneal spread, and the understanding of the protective function of the peritoneal barrier against tumoral seeding, has prompted the concept that PC is a loco-regional disease: in absence of other systemic metastases, multimodal approaches combining aggressive cytoreductive surgery, intraperitoneal hyperthermic chemotherapy and systemic chemotherapy have been proposed and are actually considered promising methods to improve loco-regional control of the disease, and ultimately to increase survival. The aim of this review article is to present the evidence on treatment of PC in different tumors, in order to provide patients with a proper surgical and multidisciplinary treatment focused on optimal control of their locoregional disease.
About the Authors
S. V. Solomenny
Bashkir State Medical University; Republican Clinical Oncology Dispansery
Russian Federation
Russian Federation
Oncology Chair with courses of Oncology and Pathoanatomy, Ufa
R. S. Minigazimov
Bashkir State Medical University; Republican Clinical Oncology Dispansery
Russian Federation
Russian Federation
Oncology Chair with courses of Oncology and Pathoanatomy, Ufa
References
1. Ганцев Ш.Х. Перитонеальный канцероматоз – новый взгляд на проблему [Электронный ресурс] // Креативная онкология и хирургия. 2013. №1 (10.03.2013). URL:http///eoncosurg. com/?p=3294(дата обращения: 13.09.2013).
2. Димитров Н. К микроскопической анатомии кровеносных сосудов диафрагмы / Морфологические основы микроциркуляции. – М., 1965. –С. 90-97.
3. Иванова В.Ф. Роль мезотелия париетальной брюшины в процессе всасывания истинных растворов и взвеси туши из брюшной полости / Бюл. экспер. биол. и мед. 1986. – Вып.10. – С. 1258-1261.
4. Скоропад В.Ю. Хирургическое лечение распро¬страненного рака желудка / В.Ю. Скоропад, Б.А. Бердов // Хирургия. 2004. № 11. С. 30-35.
5. Яценко Л.Д. Особенности метастазирования при раке желудка IV стадии/ // Онкология. 2007. Т. 9. №2. С. 139-144.
6. Cao C., Yan T.D., Black D. et al. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin // Ann Surg Oncol. – 2009. – Vol. 16. – P. 2152-2165.
7. Cavaliere F., De S.M., Virzi S. et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O // Eur J Surg Oncol. – 2011. – Vol. 37. – P. 148-154.
8. Chua T.C., Morris D.L., Saxena A. et al. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study // Ann Surg Oncol. – 2011. – Vol. 18. – P. 1560-1567.
9. Elias D., Delperro J.R., Sideris L. et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials //Ann Surg Oncol. – 2004. – Vol. 11. – P. 518-521.
10. Elias D., Lefevre J.H., Chevalier J. et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin // J Clin Oncol. – 2009. – Vol. 27. – P. 681-685.
11. Elias D., Gilly F., Boutitie F. et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study // J Clin Oncol. – 2010. – Vol. 28. – P. 63-68.
12. Esquivel J., Chua T.C., Stojadinovic A. et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study // J Surg Oncol. – 2010. – Vol. 102. – P. 565-570.
13. Effects of intraoperative chemohyperthermia in pa¬tients with gastric cancer with peritoneal dissemination / Y. Yonemura, T. Fujimura, G. Nishimura [et al.] // Surgery. 1996. – Vol. 119. №4. P. 437-444.
14. Franko J., Shi Q., Goldman C.D. et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841 // J Clin Oncol. –2012. -Vol. 30. – P. 263-267.
15. Franko J., Ibrahim Z., Gusani N.J. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis // Cancer. – 2010. – Vol. 116. – P. 3756-3762.
16. First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer / S. Iwasa, T.E. Nakajima, K. Nakamura [et al.] // Gastric Cancer. 2012. – Vol. 15. №1. P. 21-26.
17. Global cancer statistics / D.M. Parkin, F. Bray, J. Ferlay, P. Pisani // CA Cancer J. Clin. 2005. Vol. 55. №2. P. 74-108.
18. Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma / E. Bando, Y. Yone mura, Y. Takeshita [et al.] // Am. J. Surg. 1999. – Vol. 178. №3. P. 256-262.
19. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding / S. Fujimoto, R.D. Shrestha, M. Kokubun [et al.] // Ann. Surg. 1988. – Vol. 208. №1. P. 36-41.
20. Jayne D.G., Fook S., Loi C. et al. Peritoneal carcinomatosis from colorectal cancer // Br J Surg. – 2002. – Vol. 89. – P. 1545-1550.
21. Kianmanesh R., Scaringi S., Sabate J.M. et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases // Ann Surg. – 2007. – Vol. 245. – P. 597-603.
22. Kelley J.R. Gastric cancer epidemiology and risk factors / J.R. Kelley, J.M. Duggan // J. Clin. Epidemiol. 2003. Vol. 56. №1. P. 1-9.
23. Levine E.A., Blazer D.G., Kim M.K. et al. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes // J Am Coll Surg. 2012. – Vol. 214. – P. 599-606.
24. Mahteme H., Hansson J., Berglund A. et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study // Br J Cancer. – 2004. – Vol. 90. – P. 403-407.
25. Noura S., Ohue M., Shingai T. et al. Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings // Ann Surg Oncol. 2011. – Vol. 18. – P. 396-404.
26. Okajima K. Surgical treatment of far-advanced gas¬tric cancer / K. Okajima, S. Yamada // Jpn. J. Cancer Clin. 1986. Vol. 32. P. 1203-1209.
27. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon // Ann Surg. – 1994. – Vol. 219. – P. 109-111.
28. Peritoneal carcinomatosis in nongynecologic malig¬nancy: a prospective study of prognostic factors / D.Z. Chu, N.P. Lag, C. Thompson [et al.] // Cancer. 1989. – Vol. 63. №2. P. 364-367.
29. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric pro¬spective study / B. Sadeghi, C. Arvieux, O. Glehen [et al.] // Cancer. 2000. – Vol. 88. №2. P. 358-363.
30. Portilla A.G., Shigeki K., Dario B. et al. The intraoperative staging systems in the management of peritoneal surface malignancy // J Surg Oncol. – 2008. –Vol. 98. – P. 228-231.
31. Sadeghi B., Arvieux C., Glehen O. et al. Peritonealcarcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study // Cancer. – 2000. – Vol. 88. P. 358-363.
32. Sugarbaker P.H. A perspective on clinical research strategies in carcinoma of the large bowel // World J Surg. – 1991. – Vol. 15. – P. 609-616.
33. Sugarbaker P.H., Jablonski K.A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy // Ann Surg. – 1995. – Vol. 221. – P. 124-132.
34. Sugarbaker P.H. Peritonectomy procedures // Cancer Treat Res. – 2007. –Vol. 134. – P. 247-264.
35. Sugarbaker P.H. Clinical pathway for the manage¬ment of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure / P.H. Sugarbaker, Y. Yonemura // Oncology. 2000. – Vol. 58. №2. P. 96-107.
36. Verwal V.J. et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer // J Clin Oncol. – Vol. 2003. – P. 21. – Р. 3737-3743.
37. Verwal V.J., Bruin S., Boot H. et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer // Ann Surg Oncol. –2008. Vol. 15. – P. 2426-2432.
38. Vaira M., Cioppa T., D’Amico S. et al. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) // Experience of ten years. In Vivo. – 2010. Vol. 24. – P. 79-84.
Review
For citations:
Solomenny S.V., Minigazimov R.S. PERITONEAL CARCINOMATOSIS. REVIEW OF WORLD EXPERIENCE. Creative surgery and oncology. 2013;(4):115-119. (In Russ.) https://doi.org/10.24060/2076-3093-2013-0-4-115-119
Views:
1947
Email this article 